|Bid||211.75 x 900|
|Ask||222.92 x 800|
|Day's Range||209.45 - 216.26|
|52 Week Range||189.40 - 301.34|
|Beta (5Y Monthly)||0.45|
|PE Ratio (TTM)||40.70|
|Earnings Date||Aug 03, 2022 - Aug 08, 2022|
|Forward Dividend & Yield||1.68 (0.80%)|
|Ex-Dividend Date||May 11, 2022|
|1y Target Est||239.83|
Lucile Blaise, President, Sleep & Respiratory Care, ResMed Lucile Blaise, President, Sleep & Respiratory Care, ResMed Blaise is a medtech industry thought leader with over 25 years’ experienceA board member of MedTech Europe since 2020; President of the Snitem, France’s premier medtech associationPromotion effective July 1 SAN DIEGO, June 28, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced the promotion of Lucile Blaise to President of Sleep & Respiratory Care, effective Ju
Every investor in ResMed Inc. ( NYSE:RMD ) should be aware of the most powerful shareholder groups. Large companies...
ResMed's (RMD) acquisition of a renowned out-of-hospital software solutions company is expected to strengthen its SaaS business.